™™
Have
you ever wanted to…
> Have access to unbiased information about a company – whether publicly traded or private – from a source that gets paid to tell you the truth?
Bekemeier & Associates never has any financial interest in the companies we analyze;
> Purchase a report that gives you more than a mere analysis of numbers?
Bekemeier & Associates’ reports always include a “plain English” summary of the numbers along with an examination of trends and media articles that give the numbers a business context;
> Evaluate a company’s strengths and weaknesses relative to
those
of its competition?
All of Bekemeier & Associates’ reports include a marketing analysis to show how a target company compares to similar companies on variables specific to its market(s);
> Purchase an in-depth analysis of a publicly traded company’s
SEC filings,
which focuses on the subtleties buried in the numbers?
Bekemeier & Associates
specializes in condensing thousands of pages of SEC filings into a brief report
with a one-page Executive Summary that describes all issues of importance to
the target company.
Bekemeier & Associates reports allow our clients to see beyond the "media spin" put forth by a target company. We arm you with the objective facts you need to determine whether or not a company's marketing messages are:
1) Accurate; 2) Consistent with other internal or external messages; 3) Supported by the numbers.
Customization: Bekemeier & Associates does not believe in a “one-size-fits-all” approach to financial or business analyses. We customize every report to focus upon those needs most important to our clients.
Unparalleled Detail: The average Bekemeier & Associates Comprehensive Business Analysis report contains over 100 hours of manpower. We read and analyze the text and numbers of all SEC filings or Private Placement Memorandum for the previous 24 months, and cross-reference those findings with media articles, analyst reports and human source interviews.
Bekemeier & Associates analyses have thus far focused primarily
on the healthcare industry. These companies are traditionally subject to more
than
average government regulation, by virtue of having to deal with the FDA. However,
our proven techniques are equally effective in industries subject to less government
regulation.
> Seeking advice on a merger or acquisition?
> Deciding whether or not to take on a new investment-banking client?
> Considering a large-block stock purchase or investment in one company?
> Making venture capital investment decisions?
> Conducting a financial analysis?
> Researching a news story?
SAMPLE REPORTS – available by request.
Last modified: September 10, 2003
© Bekemeier & Associates, 2003